Malaysia better prepared for COVID-19 due to past experience

KUALA LUMPUR, Feb 12 -- Having experienced health crises such as Zika virus, Influenza and Nipah virus in the past, has helped Malaysia to be better prepared in handling the spread of any communicable disease.

Universiti Malaya senior consultant and Emergency Department head Assoc. Prof Datuk Dr M. Rishya said based on past experience and with several improvements following World Health Organization (WHO) guidelines, COVID-19 infection in the country could be controlled and managed satisfactorily.

"We had previously been tested with diseases such as the Middle East Respiratory Syndrome coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS) and with guidelines from the Ministry of Health Malaysia and World Health Organisation our preparedness for response had been fast,” he told Bernama after appearing as guest on the television programme ‘The Nation’, at Wisma Bernama today.

Dr M. Rishya said among the measures taken were patient isolation, limiting contact to only medical  staff  and using personal protective equipment (PPE).

"If a patient has positive signs of COVID-19 and has a history of travelling to China, they need to report at a designated area outside the emergency department  and if confirmed positive they will be placed in a separate room  for further monitoring,” he said.

At the same time Dr M. Rishya advised the public not to panic as the number of COVID-19 infection in the country is still low and they should take good care of their health and practice high standards of personal hygiene.








UKM Hospital To Conduct Study On Potential Therapy For Leukaemia

By Durratul Ain Ahmad Fuad

KUALA LUMPUR (Bernama) – A potentially effective treatment for patients with relapsed and refractory acute lymphoblastic leukaemia (ALL) is in the works.

ALL is a type of blood cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell.

Universiti Kebangsaan Malaysia’s teaching facility Hospital Canselor Tuanku Muhriz (HCTM) is collaborating with Plutonet Sdn Bhd on a study and clinical trial involving the Chimeric Antigen Receptor-T Cell (CAR-T) therapy, a revolutionary treatment found to be effective for ALL patients who cannot be treated with chemotherapy or are immune to it.



UMSC: Pain Management

In Focus : UMSC Raya Open House 2018

In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 2

In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 1

In Focus : UMSC - Fatty Liver, The Silent Epidemic Part 2